One-Year Follow-Up Results from AUGMENT-HF: A Multicentre Randomized Controlled Clinical Trial of the Efficacy of Left Ventricular Augmentation with Algisyl in the Treatment of Heart Failure

Algisyl in addition to SMT was more effective than SMT alone for providing sustained 1-year benefits in exercise capacity, symptoms, and clinical status for patients with advanced HF. These data support larger clinical evaluations of this novel therapy.